Skip to main content
Top
Published in: Current Heart Failure Reports 1/2012

01-03-2012 | Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK Hasan, Section Editor)

Clinical Use of Telemonitoring in Chronic Heart Failure: Keeping up with the Times or Misuse of Time?

Authors: Nik Stoyanov, Vince Paul

Published in: Current Heart Failure Reports | Issue 1/2012

Login to get access

Abstract

Close follow-up of patients with severe heart failure, especially after hospital discharge, has been shown to impact the mortality and readmission rates in this patient population. Monitoring of the patients’ physiological status is important for predicting a potential heart failure decompensation. Earlier studies on structured telephone support and telemonitoring suggested a clear benefit on mortality and heart failure admissions, though recent large randomized controlled trials have been neutral. This review looks into the possible reasons for discrepancies in the outcomes. Remote monitoring of implantable cardiac devices is becoming increasingly utilized in a proportion of patients for device follow-up, and recent technology advances have suggested utility of certain device algorithms in detecting heart failure decompensations. Implantable hemodynamic monitors also show promise in this sphere, though have limited evidence at this stage, and further development in the technology is likely before they become part of routine practice.
Literature
1.
go back to reference Fonarow GC, Stevenson LW, Walden JA, et al. Impact of comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol. 1997;30(3):725.PubMedCrossRef Fonarow GC, Stevenson LW, Walden JA, et al. Impact of comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol. 1997;30(3):725.PubMedCrossRef
2.
go back to reference Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults. Circulation. 2009;119:e391.PubMedCrossRef Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults. Circulation. 2009;119:e391.PubMedCrossRef
3.
go back to reference Solomon SD, Dobson J, Pocock S, et al. Candesartan in Heart Failure: Assessment of reduction in mortality and morbidity (CHARM) investigators. Circulation. 2007;116(13):1482.PubMedCrossRef Solomon SD, Dobson J, Pocock S, et al. Candesartan in Heart Failure: Assessment of reduction in mortality and morbidity (CHARM) investigators. Circulation. 2007;116(13):1482.PubMedCrossRef
4.
go back to reference GESICA Investigators. Randomised trial of telephone intervention in chronic heart failure: DIAL trial. BMJ. 2005;331:425.CrossRef GESICA Investigators. Randomised trial of telephone intervention in chronic heart failure: DIAL trial. BMJ. 2005;331:425.CrossRef
5.
go back to reference Clark RA, Inglis SC, McAlister FA, et al. Tele- monitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ. 2007;334:942.PubMedCrossRef Clark RA, Inglis SC, McAlister FA, et al. Tele- monitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ. 2007;334:942.PubMedCrossRef
6.
go back to reference • Inglis SC, Clark RA, McAlister FA, et al.: Structured telephone support or telemonitoring programmes for patients with chronic heart failure (Review). Cochrane Collaboration, The Cochrane Library 2010, Issue 8. This is a recent large meta-analysis of telephone support and telemonitoring in heart failure. • Inglis SC, Clark RA, McAlister FA, et al.: Structured telephone support or telemonitoring programmes for patients with chronic heart failure (Review). Cochrane Collaboration, The Cochrane Library 2010, Issue 8. This is a recent large meta-analysis of telephone support and telemonitoring in heart failure.
7.
go back to reference • Klersy C, De Silvestri A, Gabutti G, et al.: A meta-analysis of remote monitoring of heart failure patients. J. Am. Coll. Cardiol. 2009;54;1683–1694. This is a meta-analysis of randomized controlled trials and cohort studies in remote monitoring including telemonitoring, telephone support, devices in monitoring, and implantable hemodynamic monitors. Overall, this meta-analysis showed both telephone support and technology-assisted monitoring had hospitalization and mortality benefits. PubMedCrossRef • Klersy C, De Silvestri A, Gabutti G, et al.: A meta-analysis of remote monitoring of heart failure patients. J. Am. Coll. Cardiol. 2009;54;1683–1694. This is a meta-analysis of randomized controlled trials and cohort studies in remote monitoring including telemonitoring, telephone support, devices in monitoring, and implantable hemodynamic monitors. Overall, this meta-analysis showed both telephone support and technology-assisted monitoring had hospitalization and mortality benefits. PubMedCrossRef
8.
go back to reference Goldberg LR, Piette JD, Walsh MN, et al. A daily electronic home monitoring system in patients with advanced heart failure improves survival: the WHARF (weight monitoring in heart failure) trial. J Card Fail. 2002;8:S54. Goldberg LR, Piette JD, Walsh MN, et al. A daily electronic home monitoring system in patients with advanced heart failure improves survival: the WHARF (weight monitoring in heart failure) trial. J Card Fail. 2002;8:S54.
9.
go back to reference Cleland JG, Louis AA, Rigby AS, et al. Noninvasive home monitoring for patients with heart failure at high risk of recurren admission and death: The Ten – HMS Study. Heart Failure. 2005;45:10. Cleland JG, Louis AA, Rigby AS, et al. Noninvasive home monitoring for patients with heart failure at high risk of recurren admission and death: The Ten – HMS Study. Heart Failure. 2005;45:10.
10.
go back to reference •• Koehler F, Winkler S, Schiever M, et al.: Telemedical Intervnetional Monitoring in Heart Failure (TIM-HF), a randomizd, controlled inervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design. European Journal of Heart Failure (2010) 12, 1354–1362. This randomized controlled trial showed no benefit of telemonitoring (of parameters, namely weight, blood pressure, and ECG) over usual care in patients with severe LV failure on optimal medical therapy. Overall mortality in both groups was lower than similar studies. CrossRef •• Koehler F, Winkler S, Schiever M, et al.: Telemedical Intervnetional Monitoring in Heart Failure (TIM-HF), a randomizd, controlled inervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design. European Journal of Heart Failure (2010) 12, 1354–1362. This randomized controlled trial showed no benefit of telemonitoring (of parameters, namely weight, blood pressure, and ECG) over usual care in patients with severe LV failure on optimal medical therapy. Overall mortality in both groups was lower than similar studies. CrossRef
11.
go back to reference •• Chaudhry SI, Mattera JA, Curtis JP, et al.: Telemonitoring in Patients with Heart Failure. N Engl J Med 2010;363:2301–9. This well-designed randomized controlled trial compared a form of telemonitoring to usual care. Patients were asked to use a commercial telephone voice-response system that assessed their heart failure symptoms daily. Although the study showed no benefit on mortality or hospitalization, patient adherence to the telemonitoring system was low. PubMedCrossRef •• Chaudhry SI, Mattera JA, Curtis JP, et al.: Telemonitoring in Patients with Heart Failure. N Engl J Med 2010;363:2301–9. This well-designed randomized controlled trial compared a form of telemonitoring to usual care. Patients were asked to use a commercial telephone voice-response system that assessed their heart failure symptoms daily. Although the study showed no benefit on mortality or hospitalization, patient adherence to the telemonitoring system was low. PubMedCrossRef
12.
go back to reference HRS/EHRA Expert consensus on the monitoring of cardiovascular implantable electronic devices. Description of techniques, indications, personnel, frequency and ethical considerations. Europace. 2008;10:707–25.CrossRef HRS/EHRA Expert consensus on the monitoring of cardiovascular implantable electronic devices. Description of techniques, indications, personnel, frequency and ethical considerations. Europace. 2008;10:707–25.CrossRef
13.
go back to reference Crossley GH, Boyle A, Vitense H, et al. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) Trial: The value of wireless remote monitoring with automatic clinician alerts. JACC. 2011;57:1181–9.PubMed Crossley GH, Boyle A, Vitense H, et al. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) Trial: The value of wireless remote monitoring with automatic clinician alerts. JACC. 2011;57:1181–9.PubMed
14.
go back to reference Dries DL, Exner DV, Gersch BJ. Atrial fibrillation is associated with increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular dysfunction. J Am Coll Cardiol. 1998;S32:695–703.CrossRef Dries DL, Exner DV, Gersch BJ. Atrial fibrillation is associated with increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular dysfunction. J Am Coll Cardiol. 1998;S32:695–703.CrossRef
15.
go back to reference Madsen BK, Hansen JF, Stokholm KH, et al. Chronic congestive cardiac failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive cardiac failure based on clinical signs and symptoms. Eur Heart J. 1994;15:304–6. Madsen BK, Hansen JF, Stokholm KH, et al. Chronic congestive cardiac failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive cardiac failure based on clinical signs and symptoms. Eur Heart J. 1994;15:304–6.
16.
go back to reference Ellery S, Pakrashi T, Paul V, Sack S. Predicting mortality and rehospitalisation in heart failure patients with home monitoring–the Home CARE pilot study. Clin Res Cardiol. 2006;95 Suppl 3:III29–35.PubMedCrossRef Ellery S, Pakrashi T, Paul V, Sack S. Predicting mortality and rehospitalisation in heart failure patients with home monitoring–the Home CARE pilot study. Clin Res Cardiol. 2006;95 Suppl 3:III29–35.PubMedCrossRef
17.
go back to reference La Rovere MT, Pinna GD, Maestri R, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation. 2003;107:565–70.PubMedCrossRef La Rovere MT, Pinna GD, Maestri R, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation. 2003;107:565–70.PubMedCrossRef
18.
go back to reference Adamson PB, Smith AL, Abraham WT, et al.: Continuous Autonomic Assessment in Patients With Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device Circulation 2004; 110:2389–2394. Adamson PB, Smith AL, Abraham WT, et al.: Continuous Autonomic Assessment in Patients With Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device Circulation 2004; 110:2389–2394.
19.
go back to reference Ewald GA, Gilliam FR, Sweeney RJ. Automated HF Decompensation Detection: Results from the Decompensation Detection Study (DECODE). J Card Fail. 2009;15:S122.CrossRef Ewald GA, Gilliam FR, Sweeney RJ. Automated HF Decompensation Detection: Results from the Decompensation Detection Study (DECODE). J Card Fail. 2009;15:S122.CrossRef
20.
go back to reference Abraham WT. Intrathoracic impedance monitoring for early detection of heart failure decompensation. CHF. 2007;13:113–5.PubMed Abraham WT. Intrathoracic impedance monitoring for early detection of heart failure decompensation. CHF. 2007;13:113–5.PubMed
21.
go back to reference Yu CM, Wang L, Chau E, et al.: Intrathoracic Impedance Monitoring in Patients With Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization Circulation 2005;112:841–848 Yu CM, Wang L, Chau E, et al.: Intrathoracic Impedance Monitoring in Patients With Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization Circulation 2005;112:841–848
22.
go back to reference Abraham WT, Compton S, Haas G, et al.: Superior performance of intrathoracic impedence-derived fluid index versus daily weight monitoring in heart failure patients: Results of the fluid accumulation status trial (FAST). J Cardiac Fail 2009; 15: 9,813 Abraham WT, Compton S, Haas G, et al.: Superior performance of intrathoracic impedence-derived fluid index versus daily weight monitoring in heart failure patients: Results of the fluid accumulation status trial (FAST). J Cardiac Fail 2009; 15: 9,813
23.
go back to reference Ypenburg C, Bax JJ, Van Der Wall EE, et al. In- trathoracic impedance monitoring to predict decompensated heart failure. Am J Cardiol. 2007;99:554–7.PubMedCrossRef Ypenburg C, Bax JJ, Van Der Wall EE, et al. In- trathoracic impedance monitoring to predict decompensated heart failure. Am J Cardiol. 2007;99:554–7.PubMedCrossRef
24.
go back to reference • Catanzariti D, Lunati M, Landolina M, et al.: Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. PACE 2009; 32:363–370. In this large prospective trial, 532 patients with heart failure were followed-up after insertion of a defibrillator. The results showed a reduction in hospitalizations with the use of intrathoracic impedance monitoring (OptiVol). A proportion of patients (102) had the audible alarm for OptiVol turned off, and these patients had higher HF hospitalization rates (20%) than the patients with the alarm turned on (7%) after 11-month follow-up. PubMedCrossRef • Catanzariti D, Lunati M, Landolina M, et al.: Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. PACE 2009; 32:363–370. In this large prospective trial, 532 patients with heart failure were followed-up after insertion of a defibrillator. The results showed a reduction in hospitalizations with the use of intrathoracic impedance monitoring (OptiVol). A proportion of patients (102) had the audible alarm for OptiVol turned off, and these patients had higher HF hospitalization rates (20%) than the patients with the alarm turned on (7%) after 11-month follow-up. PubMedCrossRef
25.
go back to reference Whellan D, Ousdigian KT, Al-Khatib SM, et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalization. J Am Coll Cardiol. 2010;55:1803–10.PubMedCrossRef Whellan D, Ousdigian KT, Al-Khatib SM, et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalization. J Am Coll Cardiol. 2010;55:1803–10.PubMedCrossRef
28.
go back to reference Brachmann J, Bohm M, Rybak K, et al. Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLin HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink). Eur J Hear Fail. 2011;13:796–804.CrossRef Brachmann J, Bohm M, Rybak K, et al. Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLin HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink). Eur J Hear Fail. 2011;13:796–804.CrossRef
29.
go back to reference Bourge RC, Abraham WT, Adamson PB, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: The COMPASS-HF Study. J Am Coll Cardiol. 2008;51:1073–9.PubMedCrossRef Bourge RC, Abraham WT, Adamson PB, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: The COMPASS-HF Study. J Am Coll Cardiol. 2008;51:1073–9.PubMedCrossRef
30.
go back to reference Abraham WT, Adamson PB; CHAMPION Trial Committees and Study Group: Primary Results of the CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients (CHAMPION) Trial [abstract]. European Society of Cardiology Heart Failure Congress 2010, Berlin, Germany. Abraham WT, Adamson PB; CHAMPION Trial Committees and Study Group: Primary Results of the CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients (CHAMPION) Trial [abstract]. European Society of Cardiology Heart Failure Congress 2010, Berlin, Germany.
Metadata
Title
Clinical Use of Telemonitoring in Chronic Heart Failure: Keeping up with the Times or Misuse of Time?
Authors
Nik Stoyanov
Vince Paul
Publication date
01-03-2012
Publisher
Current Science Inc.
Published in
Current Heart Failure Reports / Issue 1/2012
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-011-0074-4

Other articles of this Issue 1/2012

Current Heart Failure Reports 1/2012 Go to the issue

Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK HASAN, Section Editor)

Resistance Versus Aerobic Exercise Training in Chronic Heart Failure

Pharmacologic Therapy (W. H. Wilson Tang, Section editor)

Cardiac Gene Therapy: From Concept to Reality

Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK Hasan, Section Editor)

Surgical Approach to Mitral Regurgitation in Chronic Heart Failure: When Is It an Option?

Pharmacologic Therapy (W. H. Wilson Tang, Section Editor)

Pharmacogenetics in Chronic Heart Failure: New Developments and Current Challenges

Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK Hasan, Section Editor)

Evaluating Heart Failure After Implantation of Mechanical Circulatory Support Devices

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.